Shares of Fluence Energy plunged to $10.79, erasing nearly a quarter of the stock's value in a single session, after the battery-storage maker missed revenue estimates by a wide margin and slashed its full-year outlook. For shareholders, the question is stark: is this an execution stumble on the way to a massive buildout, or a sign that Fluence can't scale fast enough to meet the demand it keeps winning?
• The Revenue Miss Was Far Worse Than Expected. Q3 revenue came in at $649.8 million versus analyst estimates of roughly $811 million, and the company posted a loss of $0.24 per share against expectations of a $0.01 profit.
GAAP gross margin collapsed to 5.1% from 14.8% a year ago.
Management blamed the margin contraction on delayed revenue, startup costs for new product lines, and an upfront expense tied to a long-term international battery-cell supply deal. In plain terms, Fluence spent heavily to prepare for future growth but had far less revenue to show against those costs this quarter.
• Factory Problems Pushed $400 Million of Work Into Next Year. The company pointed to manufacturing constraints at an international contract facility and construction delays at a new U.S. plant.
Those issues are expected to shift roughly $400 million in project deliveries from fiscal 2026 into fiscal 2027.
As a result, full-year revenue guidance was cut to $2.9–$3.1 billion from $3.2–$3.6 billion, and the adjusted EBITDA target swung from a $50 million profit to a roughly $10 million loss. That profit reversal is what spooked the market most — it signals Fluence won't break into the black this fiscal year.
• Demand Isn't the Problem — Execution Is. Quarterly order intake exceeded $1.44 billion, nearly triple the year-ago figure, and total backlog hit a record $6.4 billion.
Fluence also disclosed roughly $850 million of data-center-related business secured through July. The disconnect between booming orders and weak delivery underscores a classic scaling trap: winning contracts is meaningless if you can't fulfill them on time.
• Wall Street Is Trimming, Not Bailing. Morgan Stanley lowered its price target to $15 from $16 but kept a neutral rating , projecting a slower gross-margin recovery with its 2028 forecast dropping to 11.9% from 13.3%. The message: delayed revenue isn't lost revenue, but the road to profitability just got longer — and investors may need more patience than they bargained for.